All Type of News
Boryung eying sales of 10 billion won with new drug
Boryung Pharmaceutical Co. says its new drug for hypertension “Kanarb (fimasartan)”, angiotensin II receptor antagonist with a selective AT1 receptor blockade effect, is expected to achieve a 10 billion won in sales w...
Anterogen to sell stem cell treatment
Anterogen, a Korean biotechnology venture, filed an application with the Korea Food and Drug Administration Thursday to market a new drug “Cupistem”, a stem cell treatment for anal fistula in Crohn’s disease.
Crohn...
KFDA approves additional indication of Janumet
The Korea Food and Drug Administration has recently approved the additional indication of Janumet (sitagliptin+metformin), the first and only tablet combining a dipeptidyl peptidase-4 (DPP-4) inhibitor, for the treatm...
Health minister nominee urged to step down from candidacy
Watching the National Assembly's hearing on Health Minister-Designate Rim Che-min today, civil groups might have wondered whether it was really necessary.
Rim, 53, minister of the Prime Minister’s Office, is one of...
Controversy growing over drug price gap per region
Tension is escalating between pharmacy owners and a lawmaker over the gap of retail drug prices prevailing per region.
A survey of popular over-the-counter drugs nationwide showed that their price gap is bigger, Re...
Downsizing to sweep Korean drugmakers
The domestic pharmaceutical industry is expected to be the next targets for downsizing next year as Retail drug prices are expected to fall about 17 percent on average beginning next year following a set of government...
Discontent mounting over recalled contraceptives
The mislabeling of expiration date in Bayer Korea’s Melian tablets has raised public complaint over drug safety in September 2, but the company’s follow-up action goes unheeded.
According to the recent report of Ya...
Antibiotics prescription rate drops below 40%
The nation’s campaign for correct antibiotics use saw great progress in the first half of 2011, with the prescription rate falling below 40 percent for the first time.
The Health Insurance Review and Assessment Se...
Pfizer Korea to extend Viagra patent
The Korean unit of Pfizer Inc. is seeking to extend Viagra patent, which covers the indication for which the drug is used. That patent expires in October 2019. The US composition-of-matter patent is set to expire in M...
Big gap of OTC drug price prevailing per region
A survey of popular over-the-counter drugs nationwide showed that their price gap is bigger.
For example, the average price of Antiphlamine ointment by Yuhan is 1,025 won in Kwangju of Cholla Province while it is 6...
